A relatively unconventional academic journey involving training in economics, international relations, environmental science, and epidemiology put me in a unique position to solve some challenging problems in public health. My research interests now include the economic evaluation of public health interventions (including but not limited to vaccination programs) and the disease burden assessment (past and future) of environmentally-/ climate-sensitive infectious diseases. I have worked on various infectious diseases and pathogens (e.g., COVID-19, influenza, dengue fever, hand-foot-and-mouth disease, HPV, pneumococci). My research is currently supported by the Bill & Melinda Gates Foundation.

With experience in policy, my focus has always been science with a real-world impact. I have worked with public health agencies at various scales, ranging from subnational (e.g., Minnesota Department of Health) to national (e.g., U.S. CDC, China CDC) and to regional/ international levels (e.g., Africa CDC, World Health Organization). Outside of academic writing, I have developed content (e.g., presentations, dashboards, policy briefs) specifically for improving communication with policymakers.
 
I am the research degree student facilitator at the Department of Infectious Disease Epidemiology, the organiser of the Modelling and Economic Evaluation of Vaccines (MEEV) group, the lead of the spatial analysis and the vaccine themes in the Centre for Mathematical Modelling of  Infectious Diseases (CMMID), and a member of the WHO SAGE Working Group: COVID-19 Vaccine Modelling Subgroup and the WHO European Regional Working Group on COVID-19 Vaccination.